Open AccessUsing human umbilical cord mesenchymal stem cells combined with allogenic platelet-rich fibrin membrane for the treatment of dual limb ischemia in an elderly patient
Author(s) -
Wendong Ju,
Simao Fu,
Jun Huang,
Bishuang Li,
Li Wang,
Minmin Zheng,
Hang Song,
Quanyong Li,
Qiaozhi Zhou,
Mingguang He
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000025068
Subject(s) - medicine , umbilical cord , mesenchymal stem cell , ischemia , surgery , fibrin , gangrene , stem cell , pathology , biology , immunology , anatomy , genetics
Rationale: To describe the clinical effects of human umbilical cord mesenchymal stem cells (UCMSCs) combined with allogenic platelet-rich fibrin (PRF) for the treatment of lower limb ischemia in an elderly patient. Patient concerns: The patient was a 93-year-old Chinese woman with bilateral foot gangrene and ulcers lasting for 6 months. She had a prior history of Behcet's disease. Diagnoses: The admitting diagnosis for this episode was atherosclerosis bilateral limb ischemia. Interventions: First, treatment consisting of immunosuppressants, anticoagulation, antiplatelets, and anti-microbials were instituted. A UCMSC suspension was administered intravenously and injected into the lower limbs twice. An allogenic PRF membrane was externally applied 15 times over the lower limbs. Outcomes: The patient's pain improved and the 6 ulcers healed. Lessons: The combination of UCMSCs with a PRF membrane for the treatment of lower limb ischemia in an elderly patient is effective and safe. More and larger trials are needed before incorporating this therapy into mainstream treatment.